OSAKA -- Japanese medical equipment maker Arkray has developed a system that automates the culturing of insulin-producing pancreatic cells derived from induced pluripotent stem cells, or iPS cells.
Science
OSAKA -- Japanese medical equipment maker Arkray has developed a system that automates the culturing of insulin-producing pancreatic cells derived from induced pluripotent stem cells, or iPS cells.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.